Day: February 7, 2025

AB Panevėžio statybos trestas signed almost a 14 million EUR (VAT included) contract with JPackaging, a company of the asset management group TMV Capital, for the construction of a wooden pallet and pallet edging factory in Šeduva Industrial Park, Radviliškis district.A one-story building with a mezzanine will be built on a 21-hectare plot, the total area of ​​which will be almost 11 thousand sq. m, of which more than 9.7 thousand sq. m are designed for manufacturing purposes. The works are to be completed by the end of November this year.In addition to the factory, storage areas, access roads, a parking lot, outdoor engineering networks, and auxiliary facilities are also planned to be installed.The project in Šeduva is included in the list of major projects and is considered a project of national importance. More information:Tomas StukasManaging...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 – Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announced they have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States. 211At is a highly promising radioisotope currently being investigated for its potential in targeted alpha-therapies in oncology. The collaboration between Framatome and IBA aims to build a reliable and sustainable network of cutting-edge specialized...

Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025, Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of this program was announced on February 3, 2025, and executed on February 5, 2025, for an amount of €3 billion, through an off-market block trade with the long-standing shareholder L’Oréal. On February 6, 2025, Sanofi has entered into a mandate with an investment service provider for the second tranche of this program. Under the terms of this mandate, Sanofi will repurchase its own shares for a total consideration of up to €2 billion, between February 7, 2025 and December 31, 2025 at the latest1.   About Sanofi We are an innovative global...

PRINCETON JUNCTION, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) — The Board of Directors of MISTRAS Group, Inc. (NYSE: MG) is deeply saddened to announce the passing of Dr. Sotirios J. Vahaviolos, the company’s Founder, Chairman Emeritus, and Board Director, on Thursday, February 6, 2025. A visionary leader and pioneer in the field of non-destructive testing (NDT) and acoustic emission (AE), Dr. Vahaviolos founded MISTRAS (originally Physical Acoustics Corporation) in 1978 and dedicated over four decades to building it into a global leader in testing, inspection, and asset protection solutions. His expertise, leadership, and commitment to excellence were instrumental in shaping the company’s strategic direction and fostering a culture of innovation that remains at the core of MISTRAS today. “On behalf of the entire MISTRAS family, I want...

BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced the pricing of its upsized initial public offering of 10,588,233 shares of its common stock at a public offering price of $18.00 per share. In addition, Sionna has granted the underwriters a 30-day option to purchase up to 1,588,234 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. Sionna’s shares are scheduled to begin trading on the Nasdaq Global Market on February 7, 2025 under the ticker symbol “SION.”...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (“Spirit” or the “Company”) (CSE: SPIR) announces that it has filed an amended offering document dated February 6, 2025 (the “Amended Offering Document”) in connection with its previously announced brokered “best-efforts” private placement led by Canaccord Genuity Corp. (“Canaccord”) and Leede Financial Inc. (“Leede” and together with Canaccord, the “Lead Agents”), as co-lead agents on behalf of a syndicate of agents that may be formed (together with the Lead Agents, the “Agents”). Pursuant to the Amended Offering Document, the Company offers up to 20,000,000 units (each, a “Unit”) at a price of $0.15 per Unit, for gross...

Vancouver, BC, Feb. 07, 2025 (GLOBE NEWSWIRE) — Aben Minerals Ltd. (TSX-V: ABM) (OTCQB: ABNAF) (Frankfurt: R26) (“Aben” or “the Company”) announces that it has closed a non-brokered private placement financing for total gross proceeds of CAD $316,000 (the “Private Placement”). This relates to the News Release dated January 20th 2025.Aben has allotted and issued 4,514,286 units (the “Units”) at a price of CAD $0.07 per Unit. Each Unit is comprised of one common share and one full warrant (the “Warrants”). Each Warrant will entitle the holder to purchase one common share for a period of two (2) years at a price of CAD $0.10 per share.In addition, the Company has paid finder’s fees of $ $2,940 and issued 42,000 finder’s warrants (the “Finder’s Warrants”) to an arm’s-length party. Each Finder’s Warrant is exercisable into one...